Extension means the ‘majority’ of people aged 12 years and older with CF in Europe can now access therapy
News
UK-based CRO Charnwood Molecular reveals plans for ‘significant’ expansion in 2021
Company will become sole occupier of laboratory facility in Loughborough
Daiichi Sankyo’s cholesterol-lowering drugs recommended for NHS use
Nilemdo and Nustendi recommended for around 70,000 eligible adults in England with high cholesterol
Oxford Immunotec’s COVID-19 test to be used in ‘mix and match’ UK vaccine trial
Test will be used for T cell testing in study, which is evaluating different combinations of COVID-19 vaccines
RPS makes new recommendations for pharmacist independent prescribers
RPS wants to see increased use of pharmacist independent prescribers in the UK
NICE updates guideline on atrial fibrillation
Updated clinical guideline on the diagnosis and management of AF addresses several new areas
Over a quarter of UK adults have received both COVID-19 vaccine doses
UK government has also offered a first vaccine dose to all individuals in cohorts one to nine
EMA PRIME status granted for Vertex, CRISPR Therapeutics’ gene therapy CTX001
CRISPR/Cas9 gene-edited therapy is being investigated in transfusion-dependent beta thalassemia
UK cancer centre to offer breast cancer treatment at home
The Christie NHS Foundation Trust will offer the breast cancer treatment Phesgo to patients in their own homes
Chiesi’s Raxone recommended for use within NHS Wales
Medicine recommended for the treatment of visual impairment in Leber’s Hereditary Optic Neuropathy
Tagrisso moves closer towards EU approval for early-stage lung cancer
Therapy wins a positive CHMP opinion for the adjuvant treatment of early-stage EGFR-mutated NSCLC
Positive topline results for nirsevimab in RSV
Monoclonal antibody reduced lower respiratory tract infections due to RSV in healthy infants
J&J COVID-19 vaccine hold lifted in the US
Advisory committee voted to resume use of the vaccine under its emergency use authorisation
BMS’ deucravacitinib tops Otezla in two psoriasis studies
Deucravacitinib demonstrated superior skin clearance compared with Otezla
Roche’s Enspryng leads latest CHMP recommendations
CHMP adopted positive opinions for eight new medicines in its April meeting
